Bluejay Therapeutics
Drug DiscoveryWebsite
Developer of therapeutic medicines designed to provide curative treatments for serious viral and liver diseases. The company's treatment focuses on reducing viral surface antigen monoclonal antibodies...
Valuation
$820M
Market implied
Share Price
N/A
Total Raised
$243M
Last Round
Later Stage VC (Series C)
May 2024
Latest Funding Round
Later Stage VC (Series C)
May 9, 2024
$182M
raised
Investors
+13 other investors